1. Home
  2. SVRA vs INN Comparison

SVRA vs INN Comparison

Compare SVRA & INN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • INN
  • Stock Information
  • Founded
  • SVRA 2007
  • INN 2010
  • Country
  • SVRA United States
  • INN United States
  • Employees
  • SVRA N/A
  • INN N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • INN Real Estate Investment Trusts
  • Sector
  • SVRA Health Care
  • INN Real Estate
  • Exchange
  • SVRA Nasdaq
  • INN Nasdaq
  • Market Cap
  • SVRA 527.2M
  • INN 585.4M
  • IPO Year
  • SVRA N/A
  • INN 2011
  • Fundamental
  • Price
  • SVRA $3.95
  • INN $5.56
  • Analyst Decision
  • SVRA Buy
  • INN Sell
  • Analyst Count
  • SVRA 8
  • INN 2
  • Target Price
  • SVRA $6.88
  • INN $4.50
  • AVG Volume (30 Days)
  • SVRA 1.7M
  • INN 676.8K
  • Earning Date
  • SVRA 11-13-2025
  • INN 11-04-2025
  • Dividend Yield
  • SVRA N/A
  • INN 5.73%
  • EPS Growth
  • SVRA N/A
  • INN N/A
  • EPS
  • SVRA N/A
  • INN N/A
  • Revenue
  • SVRA N/A
  • INN $727,443,000.00
  • Revenue This Year
  • SVRA N/A
  • INN $1.16
  • Revenue Next Year
  • SVRA N/A
  • INN $2.54
  • P/E Ratio
  • SVRA N/A
  • INN N/A
  • Revenue Growth
  • SVRA N/A
  • INN N/A
  • 52 Week Low
  • SVRA $1.89
  • INN $3.57
  • 52 Week High
  • SVRA $4.51
  • INN $6.99
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 50.44
  • INN 59.87
  • Support Level
  • SVRA $4.14
  • INN $4.85
  • Resistance Level
  • SVRA $4.51
  • INN $5.28
  • Average True Range (ATR)
  • SVRA 0.22
  • INN 0.18
  • MACD
  • SVRA -0.05
  • INN 0.02
  • Stochastic Oscillator
  • SVRA 11.63
  • INN 95.21

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

Share on Social Networks: